PL3166634T3 - Nowe kompozycje szczepionek przeciwko wirusowi biegunki epidemicznej świń - Google Patents
Nowe kompozycje szczepionek przeciwko wirusowi biegunki epidemicznej świńInfo
- Publication number
- PL3166634T3 PL3166634T3 PL15747614T PL15747614T PL3166634T3 PL 3166634 T3 PL3166634 T3 PL 3166634T3 PL 15747614 T PL15747614 T PL 15747614T PL 15747614 T PL15747614 T PL 15747614T PL 3166634 T3 PL3166634 T3 PL 3166634T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine compositions
- diarrhea virus
- epidemic diarrhea
- porcine epidemic
- novel vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20061—Methods of inactivation or attenuation
- C12N2770/20063—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462023302P | 2014-07-11 | 2014-07-11 | |
| US201462037403P | 2014-08-14 | 2014-08-14 | |
| US201462046256P | 2014-09-05 | 2014-09-05 | |
| US201462093657P | 2014-12-18 | 2014-12-18 | |
| US201562102712P | 2015-01-13 | 2015-01-13 | |
| US201562115806P | 2015-02-13 | 2015-02-13 | |
| US201562121193P | 2015-02-26 | 2015-02-26 | |
| US201562143412P | 2015-04-06 | 2015-04-06 | |
| PCT/US2015/039475 WO2016007576A2 (en) | 2014-07-11 | 2015-07-08 | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus |
| EP15747614.4A EP3166634B1 (en) | 2014-07-11 | 2015-07-08 | Novel vaccine compositions for porcine epidemic diarrhea virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3166634T3 true PL3166634T3 (pl) | 2021-12-27 |
Family
ID=53783917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15747614T PL3166634T3 (pl) | 2014-07-11 | 2015-07-08 | Nowe kompozycje szczepionek przeciwko wirusowi biegunki epidemicznej świń |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10251950B2 (pl) |
| EP (2) | EP3166634B1 (pl) |
| CA (2) | CA3161295A1 (pl) |
| DK (1) | DK3166634T3 (pl) |
| ES (1) | ES2899204T3 (pl) |
| HR (1) | HRP20211451T1 (pl) |
| HU (1) | HUE056025T2 (pl) |
| LT (1) | LT3166634T (pl) |
| PL (1) | PL3166634T3 (pl) |
| PT (1) | PT3166634T (pl) |
| RS (1) | RS62414B1 (pl) |
| SI (1) | SI3166634T1 (pl) |
| TW (1) | TW201613558A (pl) |
| WO (1) | WO2016007576A2 (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106535930A (zh) | 2014-03-11 | 2017-03-22 | 明尼苏达大学董事会 | 猪流行性腹泻病毒疫苗及其使用方法 |
| LT3166634T (lt) | 2014-07-11 | 2021-11-10 | Zoetis Services Llc | Naujos vakcinos kompozicijos prieš kiaulių epideminės diarėjos virusą |
| AU2016225119B2 (en) | 2015-02-27 | 2021-06-03 | Iowa State University Research Foundation, Inc. | Porcine Epidemic Diarrhea Virus strains and immunogenic compositions therefrom |
| TW201731525A (zh) * | 2015-11-25 | 2017-09-16 | 薩斯喀徹溫大學 | 治療、預防及診斷豬流行性下痢病毒感染之方法 |
| WO2017123201A1 (en) * | 2016-01-11 | 2017-07-20 | Zoetis Services Llc | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus |
| CN105861744A (zh) * | 2016-03-24 | 2016-08-17 | 天津出入境检验检疫局动植物与食品检测中心 | 用于快速等温检测猪德尔塔冠状病毒的引物组和方法 |
| CN105861756A (zh) * | 2016-06-16 | 2016-08-17 | 天津市畜牧兽医研究所 | 一种用于检测猪德尔塔冠状病毒的引物及应用 |
| JP6253210B1 (ja) * | 2016-08-17 | 2017-12-27 | 一般財団法人日本生物科学研究所 | 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット |
| CN107815440A (zh) * | 2016-09-14 | 2018-03-20 | 华中农业大学 | 猪德尔塔冠状病毒株的分离、灭活疫苗的制备与应用 |
| CN106518989B (zh) * | 2016-11-16 | 2020-12-11 | 江苏省农业科学院 | 用于检测猪Delta冠状病毒抗体的多肽、制备方法及其应用 |
| US20200038504A1 (en) * | 2017-01-30 | 2020-02-06 | Boehringer Ingelheim Animal Health USA Inc. | Porcine coronavirus vaccines |
| CN107899007B (zh) * | 2017-11-06 | 2018-12-28 | 陕西诺威利华生物科技有限公司 | 猪流行性腹泻、猪传染性胃肠炎和猪δ冠状病毒的三联灭活疫苗及其制备方法 |
| CN110314228B (zh) * | 2017-11-07 | 2022-10-28 | 陕西诺威利华生物科技有限公司 | 猪流行性腹泻、猪δ冠状病毒二联灭活疫苗以及其制备方法 |
| CN107899008B (zh) * | 2017-11-08 | 2019-05-10 | 陕西诺威利华生物科技有限公司 | 一种猪流行性腹泻、猪传染性胃肠炎、猪丁型冠状病毒病三联亚单位疫苗 |
| CN109796531B (zh) * | 2017-11-15 | 2022-03-11 | 中国农业科学院上海兽医研究所 | 猪Delta冠状病毒N蛋白单克隆抗体及其抗原表位和应用 |
| CN108315490B (zh) * | 2018-04-20 | 2022-03-11 | 咸阳职业技术学院 | 猪急性腹泻综合征冠状病毒与德尔塔冠状病毒rt-pcr诊断试剂盒及其检测方法 |
| JP2022514307A (ja) | 2018-12-20 | 2022-02-10 | インターベット インターナショナル ベー． フェー． | プライム－ブーストワクチン接種レジメン |
| CN110144332B (zh) * | 2019-05-13 | 2020-12-08 | 中国农业科学院兰州兽医研究所 | 一株猪德尔塔冠状病毒毒株及其应用 |
| US11413347B2 (en) | 2019-09-02 | 2022-08-16 | Reber Genetics Co., Ltd. | Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine |
| TWI703983B (zh) * | 2019-09-25 | 2020-09-11 | 台灣糖業股份有限公司 | 豬流行性下痢病毒ts分離株及其用途 |
| CN110960675B (zh) * | 2019-12-17 | 2024-02-06 | 天康生物制药有限公司 | 仔猪腹泻防控用肚脐贴片疫苗及其制备方法 |
| CN112662821A (zh) * | 2021-01-30 | 2021-04-16 | 福建傲农生物科技集团股份有限公司 | 一种猪流行性腹泻病毒m基因的荧光探针引物组合、试剂盒及应用 |
| CN114790448B (zh) * | 2022-03-21 | 2023-03-31 | 华中农业大学 | 一株猪δ冠状病毒强毒株及其在疫苗制备中的应用 |
| CN116253798B (zh) * | 2022-12-15 | 2023-10-27 | 华中农业大学 | 一株针对猪δ冠状病毒S1蛋白构象表位的中和性单克隆抗体 |
| CN116875562B (zh) * | 2023-07-14 | 2024-06-14 | 河南农业大学 | 一株猪δ冠状病毒传代致弱毒株及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| MX9301736A (es) * | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
| TW579372B (en) * | 1998-07-29 | 2004-03-11 | Sumitomo Chemical Co | Process for producing alumina sintered body |
| AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
| US6974577B2 (en) * | 2001-02-04 | 2005-12-13 | Novartris Ag | Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
| PL1613346T3 (pl) * | 2003-04-04 | 2013-03-29 | Zoetis Services Llc | Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek |
| KR100502008B1 (ko) | 2003-04-29 | 2005-07-18 | 녹십자수의약품(주) | 약독화된 돼지 유행성설사병 바이러스, 그를 포함하는면역원성 조성물 및 상기 바이러스를 검출하는 방법 |
| KR100962179B1 (ko) * | 2008-03-20 | 2010-06-10 | 주식회사한국야쿠르트 | 돼지 유행성 설사병 바이러스 감염을 억제하는 신규락토바실러스 루테리 에이취와이 25101 및 이를 함유하는사료첨가제 |
| KR101484469B1 (ko) * | 2010-10-26 | 2015-01-21 | 주식회사 중앙백신연구소 | 돼지 써코바이러스 관련 질환을 예방하기 위한 ｐｃｖ-2의 전체 바이러스를 포함하는 혼합백신 |
| BR112016005948A2 (pt) | 2013-09-19 | 2017-09-26 | Zoetis Services Llc | adjuvantes com base em óleo |
| EA201691993A1 (ru) | 2014-04-03 | 2017-02-28 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина к вирусу эпидемической диареи свиней |
| WO2015179412A1 (en) | 2014-05-19 | 2015-11-26 | Merial, Inc. | Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (pedv) |
| LT3166634T (lt) * | 2014-07-11 | 2021-11-10 | Zoetis Services Llc | Naujos vakcinos kompozicijos prieš kiaulių epideminės diarėjos virusą |
| CN107075487A (zh) | 2014-08-08 | 2017-08-18 | 乌得勒支大学控股有限公司 | 突变的猪流行性腹泻病毒用于在疫苗中的用途 |
| CN104383528B (zh) * | 2014-10-24 | 2016-08-24 | 江苏省农业科学院 | 猪流行性腹泻灭活疫苗及其制备方法 |
-
2015
- 2015-07-08 LT LTEPPCT/US2015/039475T patent/LT3166634T/lt unknown
- 2015-07-08 EP EP15747614.4A patent/EP3166634B1/en active Active
- 2015-07-08 CA CA3161295A patent/CA3161295A1/en active Pending
- 2015-07-08 EP EP21183684.6A patent/EP3954385A1/en active Pending
- 2015-07-08 HU HUE15747614A patent/HUE056025T2/hu unknown
- 2015-07-08 PL PL15747614T patent/PL3166634T3/pl unknown
- 2015-07-08 WO PCT/US2015/039475 patent/WO2016007576A2/en active Application Filing
- 2015-07-08 RS RS20211228A patent/RS62414B1/sr unknown
- 2015-07-08 HR HRP20211451TT patent/HRP20211451T1/hr unknown
- 2015-07-08 ES ES15747614T patent/ES2899204T3/es active Active
- 2015-07-08 DK DK15747614.4T patent/DK3166634T3/da active
- 2015-07-08 US US15/324,908 patent/US10251950B2/en active Active
- 2015-07-08 PT PT157476144T patent/PT3166634T/pt unknown
- 2015-07-08 CA CA2954632A patent/CA2954632C/en active Active
- 2015-07-08 SI SI201531722T patent/SI3166634T1/sl unknown
- 2015-07-13 TW TW104122566A patent/TW201613558A/zh unknown
-
2019
- 2019-02-22 US US16/282,953 patent/US10953088B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE056025T2 (hu) | 2022-01-28 |
| US20190216919A1 (en) | 2019-07-18 |
| CA2954632C (en) | 2022-08-30 |
| TW201613558A (en) | 2016-04-16 |
| CA3161295A1 (en) | 2016-01-14 |
| EP3166634A2 (en) | 2017-05-17 |
| ES2899204T3 (es) | 2022-03-10 |
| WO2016007576A3 (en) | 2016-03-03 |
| CA2954632A1 (en) | 2016-01-14 |
| RS62414B1 (sr) | 2021-10-29 |
| US20170202951A1 (en) | 2017-07-20 |
| WO2016007576A8 (en) | 2016-12-22 |
| WO2016007576A2 (en) | 2016-01-14 |
| US10953088B2 (en) | 2021-03-23 |
| EP3954385A1 (en) | 2022-02-16 |
| HRP20211451T1 (hr) | 2021-12-24 |
| DK3166634T3 (da) | 2021-09-27 |
| EP3166634B1 (en) | 2021-08-18 |
| LT3166634T (lt) | 2021-11-10 |
| PT3166634T (pt) | 2021-09-29 |
| US10251950B2 (en) | 2019-04-09 |
| SI3166634T1 (sl) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE056025T2 (hu) | Új oltóanyag-készítmények sertések járványos hasmenésének vírusa ellen | |
| ZA201801035B (en) | Vaccine compositions | |
| HK1246658A1 (zh) | 豬流行性腹瀉病毒品種及其免疫原性組合物 | |
| PL3271421T3 (pl) | Utwardzalne kompozycje silikonowe | |
| SG11201609059TA (en) | Fuel compositions | |
| IL250200A0 (en) | Curable organopolysiloxane compositions | |
| IL248223A0 (en) | Compositions of vaccine | |
| EP3131579A4 (en) | Vaccine adjuvant compositions | |
| SG11201701256RA (en) | Vaccine compositions against dengue virus diseases | |
| SG11201606035RA (en) | Fuel compositions | |
| ZA201801496B (en) | Vlp stabilized vaccine compositions | |
| GB201516711D0 (en) | Fast curing compositions | |
| GB201408167D0 (en) | Compositions | |
| HK1243341A1 (zh) | 起泡減少的疫苗組合物 | |
| GB2562241B (en) | Vaccine compositions | |
| ZA201703115B (en) | Long acting pharmaceutical compositions for hepatitis c | |
| GB201604755D0 (en) | Immunogenic compositions | |
| GB201718251D0 (en) | Vaccine Compositions | |
| PL3160263T3 (pl) | Kompozycje do zapobiegania zakażeniom | |
| GB2564901B (en) | Vaccine compositions | |
| GB201611084D0 (en) | Vaccine compositions | |
| GB201521608D0 (en) | Vaccine composition | |
| GB201401883D0 (en) | Combination immunogenic compositions | |
| GB201415634D0 (en) | Novel compositions | |
| EP3116537A4 (en) | Immunogenic compositions |